These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8767613)
1. [Paroxysmal nocturnal dyspnea as a severe expression of the pacemaker syndrome]. Minutiello L Minerva Cardioangiol; 1996 Mar; 44(3):133-40. PubMed ID: 8767613 [TBL] [Abstract][Full Text] [Related]
3. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Wilkoff BL; Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277 [TBL] [Abstract][Full Text] [Related]
4. [Prevention of atrial fibrillation by atrial-based pacemaker implantation]. Lörincz I; Vaszily M; Szabó Z; Horváth G; Kovács P; Polgár P; Karányi Z; Wórum F Orv Hetil; 1999 Oct; 140(43):2393-7. PubMed ID: 10624110 [TBL] [Abstract][Full Text] [Related]
5. Paradoxical paroxysmal nocturnal congestive heart failure as a severe manifestation of the pacemaker syndrome. Parsonnet V; Myers M; Perry GY Am J Cardiol; 1990 Mar; 65(9):683-5. PubMed ID: 2309639 [No Abstract] [Full Text] [Related]
6. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA; Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566 [TBL] [Abstract][Full Text] [Related]
8. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). Link MS; Hellkamp AS; Estes NA; Orav EJ; Ellenbogen KA; Ibrahim B; Greenspon A; Rizo-Patron C; Goldman L; Lee KL; Lamas GA; J Am Coll Cardiol; 2004 Jun; 43(11):2066-71. PubMed ID: 15172414 [TBL] [Abstract][Full Text] [Related]
9. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function. Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936 [TBL] [Abstract][Full Text] [Related]
10. [Complications of single chamber pacemakers (pacemaker syndrome). Short-term and long-term follow-up of 278 patients]. Jazra C; Bakhos R J Med Liban; 1993; 41(1):4-10. PubMed ID: 8057335 [TBL] [Abstract][Full Text] [Related]
11. [Single-chamber atrial pacing is better than single chamber ventricular pacing in patients with sick sinus syndrome. Results of long-term follow up in a prospective randomized study]. Nielsen JC; Mortensen PT; Thuesen L; Nielsen TV; Thomsen PE; Pedersen AK; Andersen HR Ugeskr Laeger; 1999 Feb; 161(5):587-92. PubMed ID: 9989193 [TBL] [Abstract][Full Text] [Related]
12. Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial. Tsai CT; Lai LP; Hwang JJ; Wang YC; Chiang FT; Lin JL Am Heart J; 2008 Jul; 156(1):65-70. PubMed ID: 18585498 [TBL] [Abstract][Full Text] [Related]
13. Immediate relief of congestive heart failure by ventricular pacing in chronic bradycardia. Ntalianis A; Nanas JN Cardiol Rev; 2006; 14(5):e14-5. PubMed ID: 16924158 [TBL] [Abstract][Full Text] [Related]
14. Adverse events with transvenous left ventricular pacing in patients with severe heart failure: early experience from a single centre. Valls-Bertault V; Mansourati J; Gilard M; Etienne Y; Munier S; Blanc JJ Europace; 2001 Jan; 3(1):60-3. PubMed ID: 11271954 [TBL] [Abstract][Full Text] [Related]
16. The pacemaker syndrome: a haemodynamic complication of ventricular pacing. Witte J; Bondke H; Müller S Cor Vasa; 1988; 30(6):393-9. PubMed ID: 3234005 [TBL] [Abstract][Full Text] [Related]
17. [Biventricular pacing using two pacemakers and triggered VVT mode in patients with atrial fibrillation and congestive heart failure: a case report]. Yamakawa Y; Ishikawa T; Uchino K; Sumita S; Mochida Y; Ebina T; Kobayashi S; Kobayashi T; Matsushita K; Okusu Y; Tanaka Y; Kitamura Y; Umemura S J Cardiol; 2002 Apr; 39(4):221-5. PubMed ID: 11977770 [TBL] [Abstract][Full Text] [Related]
18. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy. Deniz HB; Caro JJ; Ward A; Moller J; Malik F J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):43-50. PubMed ID: 18268418 [TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation. Sielski J; Janion M; Gawor Z Kardiol Pol; 2005 Mar; 62(3):202-9; discussion 210. PubMed ID: 15830014 [TBL] [Abstract][Full Text] [Related]
20. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation. Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]